Lungs News and Research

RSS

Soy supplement does not improve lung function, clinical outcomes in patients with asthma

Although some data have suggested that supplementation with soy isoflavone may be an effective treatment for patients with poor asthma control, a randomized trial that included nearly 400 children and adults found that use of the supplement did not result in improved lung function or clinical outcomes, including asthma symptoms and episodes of poor asthma control, according to a study in the May 26 issue of JAMA.

27 May 2015

Tiny drug-delivery system can help identify brain tumor types through 'virtual biopsies'

Biomedical researchers at Cedars-Sinai have invented a tiny drug-delivery system that can identify cancer cell types in the brain through "virtual biopsies" and then attack the molecular structure of the disease.

27 May 2015

Medic Vision announces introduction of SafeCT Dose Reporting for healthcare providers

Medic Vision Imaging Solutions, Ltd., the leading innovator of vendor-independent image enhancement solutions for low-dose CT exams, announced today the introduction and availability of SafeCT Dose Reporting. Healthcare facilities can now, for the first time, use a single software platform to meet their low dose CT imaging needs while also conforming to CT dose monitoring and reporting standards.

27 May 2015

Researchers make important breakthrough in identifying major drivers of excessive coughing

Cough treatments could change dramatically after the herpes virus helped researchers discover that the respiratory tract links to two different parts of the nervous system.

27 May 2015

UC Davis researchers show feasibility of using statins to treat asthma

Statins continue to show that their benefits extend beyond their original focus of lowering high cholesterol. With the increasing prevalence of asthma, scientists are studying the effects of statins in the lungs.

26 May 2015

Researchers discover new gene subgroup that drives prostate cancer

Prostate cancer researchers have drawn a molecular portrait that provides the first complete picture of localized, multi-focal disease within the prostate and also unveils a new gene subgroup driving it.

26 May 2015

Researchers create 'brainstorm barometer' to calculate the brain functions of very premature infants

University of Helsinki researchers have partnered with Swedish and Australian researchers to create a "brainstorm barometer", which allows computers to calculate the brain functions of very premature babies during their first hours of life.

25 May 2015

Esophageal cancer patients treated with proton therapy experience less toxic side effects

New research by scientists at the University of Maryland School of Medicine has found that esophageal cancer patients treated with proton therapy experienced significantly less toxic side effects than patients treated with older radiation therapies.

24 May 2015

Research finds association between fine particulate air pollution and childhood autism risk

Exposure to fine particulate air pollution during pregnancy through the first two years of a child's life may be associated with an increased risk of the child developing autism spectrum disorder (ASD), a condition that affects one in 68 children, according to a University of Pittsburgh Graduate School of Public Health investigation of children in southwestern Pennsylvania.

22 May 2015

Prediagnostic lung function impairment common in older asthma patients

Older adults with newly diagnosed asthma are not only more likely to have pre-existing lung function impairment than younger adults, but they also experience a more rapid decline of lung function, a Danish team reports in Respiratory Medicine.

21 May 2015

Johns Hopkins scientists safely use immune cells to treat multiple myeloma

In a report on what is believed to be the first small clinical trial of its kind, researchers at the Johns Hopkins Kimmel Cancer Center say they have safely used immune cells grown from patients' own bone marrow to treat multiple myeloma, a cancer of white blood cells.

21 May 2015

Enterprise Therapeutics secures additional funding to accelerate drug discovery for treatment of respiratory diseases

ENTERPRISE THERAPEUTICS Ltd, a drug discovery company focused on new therapeutics for respiratory diseases, today announced that it has secured an additional £2.4m ($3.6m) in Series-A financing.

21 May 2015

Scripps Proton Therapy Center reports exceptional results in treating patients with pencil-beam scanning

The nation's first and only proton therapy center to treat patients exclusively with pencil-beam scanning is reporting exceptional results in delivering cancer treatment since opening for patient care just more than a year ago.

21 May 2015

Research may offer new targets for diagnosing, treating advanced prostate cancer

Researchers with the Indiana University School of Medicine have identified a molecule that promotes metastasis of advanced prostate cancer to the bone, an incurable condition that significantly decreases quality of life.

20 May 2015

Discovery Lab enrolls first patient in phase 2a clinical trial of AEROSURF

Discovery Laboratories, Inc., a specialty biotechnology company focused on developing aerosolized KL4 surfactant therapies for respiratory diseases, today reported that the first patient has been enrolled in the next phase of its phase 2a clinical evaluation of AEROSURF, which is designed to evaluate the safety and tolerability of higher and repeat doses of aerosolized KL4 surfactant administered to premature infants 29 to 34 weeks gestational age (GA) who are receiving nasal continuous positive airway pressure (nCPAP) for respiratory distress syndrome (RDS), compared to infants receiving nCPAP alone.

20 May 2015

Johns Hopkins researchers identify new therapy to treat lung cancer

A multidisciplinary team led by Johns Hopkins researcher Venu Raman, Ph.D., with notable contributions from Guus Bol, Farhad Vesuna and Phuoc Tran of Johns Hopkins, has identified a new therapy for lung cancer, the most common cancer worldwide. The therapy has been in development for six years and involves a first-in-class molecule designed by the team.

20 May 2015

Lakewood-Amedex's novel class of antimicrobials prove effective at killing MDR-TB strains

Lakewood-Amedex Inc., a leading developer of novel anti-infective pharmaceuticals, announced today that a recent series of in vitro studies conducted by Southern Research in Birmingham, Alabama, have demonstrated that its novel class of antimicrobials, named bisphosphocins, have proven effective at killing multidrug-resistant (MDR) strains of Mycobacterium tuberculosis, the bacteria responsible for the chronic lung infection tuberculosis.

19 May 2015

University of Missouri researchers identify key protein component that causes cystic fibrosis

Nearly 70,000 people worldwide are living with cystic fibrosis, a life-threatening genetic disease. There currently is no cure for the condition, but researchers from the University of Missouri have identified a key component in the protein that causes the disease. It is a finding that may lay the foundation for the development of new medications and improved therapies.

19 May 2015

Study: Air pollution, impaired lung function independently affect cognition

Studies have shown that both air pollution and impaired lung function can cause cognitive deficits, but it was unclear whether air pollution diminishes cognition by reducing breathing ability first or whether air pollution represents an independent risk factor for cognitive deficit.

19 May 2015

Two-drug combination improves lung function in some cystic fibrosis patients

The combination of two drugs — an investigational drug used in conjunction with an already FDA-approved medication — improved lung function in patients with one form of cystic fibrosis, according to two new studies.

19 May 2015

Lungs News and Research

Soy supplement does not improve lung function, clinical outcomes in patients with asthma

Tiny drug-delivery system can help identify brain tumor types through 'virtual biopsies'

Medic Vision announces introduction of SafeCT Dose Reporting for healthcare providers

Researchers make important breakthrough in identifying major drivers of excessive coughing

UC Davis researchers show feasibility of using statins to treat asthma

Researchers discover new gene subgroup that drives prostate cancer

Researchers create 'brainstorm barometer' to calculate the brain functions of very premature infants

Esophageal cancer patients treated with proton therapy experience less toxic side effects

Research finds association between fine particulate air pollution and childhood autism risk

Prediagnostic lung function impairment common in older asthma patients

Johns Hopkins scientists safely use immune cells to treat multiple myeloma

Enterprise Therapeutics secures additional funding to accelerate drug discovery for treatment of respiratory diseases

Scripps Proton Therapy Center reports exceptional results in treating patients with pencil-beam scanning

Research may offer new targets for diagnosing, treating advanced prostate cancer

Discovery Lab enrolls first patient in phase 2a clinical trial of AEROSURF

Johns Hopkins researchers identify new therapy to treat lung cancer

Lakewood-Amedex's novel class of antimicrobials prove effective at killing MDR-TB strains

University of Missouri researchers identify key protein component that causes cystic fibrosis

Study: Air pollution, impaired lung function independently affect cognition

Two-drug combination improves lung function in some cystic fibrosis patients

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest News